This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (39)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

An Assessment Based on 50 Years of Experience With Radical Mastectomy

Donald J. Ferguson, MD; Paul Meier, PhD; Theodore Karrison, MS; Peter J. Dawson, MD; Francis H. Straus, MD; Florence E. Lowenstein

JAMA. 1982;248(11):1337-1341.

Abstract
The correlation of staging criteria for mammary carcinoma with the curability of primary and recurrent local and regional lesions was assessed by follow-up after 1,259 consecutive radical mastectomies performed in women under age 70 between 1927 and 1978. Using a staging scheme revised in the light of our experience, the incidence of recurrence by 20 years was 34% ±2.7% for pathological stage I, 65% ±2.6% for stage II, and 83% ±2.5% for stage III. Recurrence after 20 years was observed in one of 178 patients. After treatment of local recurrence, three of 51 patients survived 20 years. By restriction of entry into clinical or pathological stages I and II, currently employed revisions of staging criteria appear to increase survival in all stages, while placing patients with possibly curable lesions in stages III and IV.

(JAMA 1982;248:1337-1341)

Author Affiliations
From the Departments of Surgery (Dr Ferguson), Statistics (Dr Meier and Mr Karrison), and Pathology (Drs Straus and Dawson) and the Tumor Registry (Ms Lowenstein), University of Chicago.

Footnotes
Reprint requests to Box 402, University of Chicago, 950 E 59th St, Chicago, IL 60637 (Dr Ferguson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Progression of Breast Cancer Malignant Behavior: What to Expect and When to Expect it
Heimann and Hellman
JCO 2000;18:591-591.
ABSTRACT | FULL TEXT  

Separating Favorable from Unfavorable Prognostic Markers in Breast Cancer: The Role of E-Cadherin
Heimann et al.
Cancer Res. 2000;60:298-304.
ABSTRACT | FULL TEXT  

The Treatment of Breast Cancer: II. A 20-Year Follow-up and Reappraisal of the En Bloc Principle
Peterson
Arch Surg 1988;123:1059-1062.
ABSTRACT